EP2034844

Aðferð til meðhöndlunar á garnaertingarheilkennum með ríkjandi niðurgangi

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    30.4.2007
  • EP published:
    22.3.2017
  • EP application number:
    07761541.7
  • Max expiry date:
    29.4.2027
  • Expiry date:
    29.4.2026
  • Next due date:
    30.4.2026
  • Title:
    METHOD FOR TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME

Timeline

Today
30.4.2007EP application
22.3.2017EP Publication
17.5.2017Translation submitted
15.6.2017Registration published
29.4.2026Expires

Owner

  • Name:
    Napo Pharmaceuticals, Inc.
  • Address:
    250 E. Grand Avenue, Suite 90, 94080-4824, South San Francisco, CA, US

Inventor

  • Name:
    QUART, Barry
  • Address:
    Encinitas, CA, US
  • Name:
    ROSENBAUM, David
  • Address:
    Waban, MA, US
  • Name:
    NEENAN, Thomas
  • Address:
    Lexington, MA, US
  • Name:
    BLANKS, Robert
  • Address:
    Auburndale, MA, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    797074 P
  • Date:
    1.5.2006
  • Country:
    US
  • Number:
    510152
  • Date:
    24.8.2006
  • Country:
    US

Classification

  • Categories:
    A61K 36/47, A61K 36/38, A61K 31/365, A61K 31/426, A61P 1/12, A61K 9/28, A61K 31/353

Annual fees

Number

Paid

Expires

Payer

Number: 11

Paid: 8.5.2017

Expires: 29.4.2018

Payer: Árnason Faktor

Number: 12

Paid: 5.3.2018

Expires: 29.4.2019

Payer: Árnason Faktor

Number: 13

Paid: 29.4.2019

Expires: 29.4.2020

Payer: Árnason Faktor

Number: 14

Paid: 23.4.2020

Expires: 29.4.2021

Payer: Örn Þór slf.

Number: 15

Paid: 16.3.2021

Expires: 29.4.2022

Payer: Örn Þór slf.

Number: 16

Paid: 21.3.2022

Expires: 29.4.2023

Payer: Árnason Faktor ehf.

Number: 17

Paid: 21.3.2023

Expires: 29.4.2024

Payer: Árnason Faktor ehf.

Number: 18

Paid: 19.3.2024

Expires: 29.4.2025

Payer: Árnason Faktor ehf.

Number: 19

Paid: 18.3.2025

Expires: 29.4.2026

Payer: Árnason Faktor ehf.

Upload documents